TipRanks
GC Biopharma Corp. (KR:006280)
:006280
South Korea Market
006280
GC Biopharma Corp.
RESEARCH TOOLSreports

GC Biopharma Corp. (006280) Financial Statements

― Followers

GC Biopharma Corp. Financial Overview

GC Biopharma Corp.'s market cap is currently ₩1.44T. The company's EPS TTM is $-4372.16; its P/E ratio is -28.57; and it has a dividend yield of 1.20%. GC Biopharma Corp. is scheduled to report earnings on July 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 1.99T₩ 1.68T₩ 1.63T₩ 1.71T₩ 1.54T
Gross Profit₩ 536.00B₩ 481.93B₩ 484.63B₩ 581.80B₩ 520.59B
Operating Income₩ 67.81B₩ 32.11B₩ 34.44B₩ 81.26B₩ 73.66B
EBITDA₩ 155.46B₩ 80.36B₩ 109.81B₩ 187.04B₩ 159.01B
Net Income₩ -4.67B₩ -26.28B₩ -26.63B₩ 65.45B₩ 123.21B
Balance Sheet
Cash & Short-Term Investments₩ 50.80B₩ 24.00B₩ 55.51B₩ 112.31B₩ 202.94B
Total Assets₩ 2.97T₩ 2.74T₩ 2.64T₩ 2.53T₩ 2.46T
Total Debt₩ 982.14B₩ 828.14B₩ 724.02B₩ 575.54B₩ 606.57B
Net Debt₩ 932.77B₩ 805.58B₩ 674.32B₩ 470.18B₩ 420.51B
Total Liabilities₩ 1.58T₩ 1.26T₩ 1.10T₩ 958.90B₩ 962.39B
Stockholders' Equity₩ 1.22T₩ 1.25T₩ 1.30T₩ 1.33T₩ 1.27T
Cash Flow
Free Cash Flow₩ 27.10B₩ -95.85B₩ -131.46B₩ 24.46B₩ 2.44B
Operating Cash Flow₩ 99.46B₩ -53.46B₩ -5.47B₩ 119.15B₩ 125.98B
Investing Cash Flow₩ -186.65B₩ -67.89B₩ -150.24B₩ -205.26B₩ -132.08B
Financing Cash Flow₩ 111.44B₩ 93.85B₩ 100.51B₩ -2.48B₩ -41.27B
Currency in KRW

GC Biopharma Corp. Earnings and Revenue History

Income Statement >

GC Biopharma Corp. Debt to Assets

Balance Sheet >

GC Biopharma Corp. Cash Flow

Cash Flow >

GC Biopharma Corp. Forecast EPS vs Actual EPS

Earnings >